Status:
RECRUITING
TDCS Stimulation After Covid-19 Infection
Lead Sponsor:
Istanbul Medipol University Hospital
Collaborating Sponsors:
Alanya Alaaddin Keykubat University
Conditions:
COVID-19
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
In this study, the effects of bilateral stimulation of the dorsolateral prefrontal cortex (DLPFC) with active tDCS (transcranial direct stimulation/transcranial direct stimulation) on neurocognitive (...
Detailed Description
The DMN is active when not engaged in a goal-oriented activity and at rest. Resting DNM is especially active when the mind is busy with introspective situations (Barkhof et al., 2014; Mak et al., 2017...
Eligibility Criteria
Inclusion
- Have received a positive value from the COVID-19 RT-PCR test in the last 60 days and turned negative
- Being between the ages of 18-50
- 21 days have passed since the disease onset date
Exclusion
- Having any neurological or psychiatric disease
Key Trial Info
Start Date :
October 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06183424
Start Date
October 1 2023
End Date
December 1 2025
Last Update
May 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alanya Alaaddin Keykubat Üniversitesi
Antalya, Turkey (Türkiye)